Antibodies to OPGL

Details for Australian Patent Application No. 2012216429 (hide)

Owner Amgen Fremont Inc. Amgen Inc.

Inventors Boyle, William J.; Martin, Francis H.; Corvalan, Jose R.; Davis, Geoffrey C.

Agent Shelston IP

Pub. Number AU-A-2012216429

Parent 2008261137

Filing date 24 August 2012

Wipo publication date 13 September 2012

International Classifications

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61K 38/00 Medicinal preparations containing peptides

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 Medicinal preparations containing active ingredients not provided for in groups

A61P 19/08 Drugs for skeletal disorders

A61P 19/10 Drugs for skeletal disorders

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/02 Drugs for immunological or allergic disorders

C07D 475/10 Heterocyclic compounds containing pteridine ring systems

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

6 September 2012 Complete Application Filed

13 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216429

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216430-Woodworking facility

2012216428-Systems and methods for collecting, storing and processing inspection data